SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-064616
Filing Date
2017-12-21
Accepted
2017-12-21 08:00:58
Documents
5
Period of Report
2017-12-15
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv481770_8k.htm 8-K 18220
2 EXHIBIT 3.1 tv481770_ex3-1.htm EX-3.1 40115
3 EXHIBIT 99.1 tv481770_ex99-1.htm EX-99.1 18871
4 GRAPHIC image_001.jpg GRAPHIC 17828
5 GRAPHIC image_002.jpg GRAPHIC 746
  Complete submission text file 0001144204-17-064616.txt   104348
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 171268026
SIC: 2834 Pharmaceutical Preparations